MCK Q4 2020 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q4 2020 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$58.5B+11.6% YoY

Gross Profit

$3.1B5.3% margin

Operating Income

$1.2B2.1% margin

Net Income

$1.0B1.7% margin

EPS (Diluted)

$5.85

QoQ Revenue Growth

-1.1%

Cash Flow

Operating Cash Flow

$4.7B

Free Cash Flow

$4.5B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$61.2B

Total Liabilities

$54.5B

Stockholders' Equity

$5.1B

Cash & Equivalents

$4.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58.5B	$52.4B	+11.6%
Gross Profit	$3.1B	$2.9B	+7.0%
Operating Income	$1.2B	$883M	+36.8%
Net Income	$1.0B	-$796M	+228.3%

Revenue Segments

U.S. Pharmaceutical Segment

$46.3B95%

Medical-Surgical Solutions Segment

$2.2B5%

Geographic Segments

UNITED STATES

$48.8B83%

International Segment

$9.7B17%